SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

Sangamo Announces Global Collaboration With Novartis to Develop Genomic Medicines for Autism and Other Neurodevelopmental Disorders; Sangamo Will Receive A $75M Upfront; Eligible To Receive Up To $720M In Potential Milestones

Benzinga · -